ARCHIVES

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

This article is from The Cancer Letter archive.

Vol. 11 No. 31 | August 2, 1985

Download PDF Visit The Full Archive

Related Articles

In Congress: Senate, House Reports List Priorities For NCI

August 8, 1997

NCI-Approved Clinical Trials

January 27, 2006

NCI-Approved Clinical Trials Listed For Month Of March

April 27, 2001

Staff Advisory Boards To Be Formed; Three BSCs Proposed

August 11, 1995

FDA: Oncology Division Director Delap Promoted In Agency

May 29, 1998

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994